ETV2 primes hematoendothelial gene enhancers prior to hematoendothelial fate commitment.
Steimle JD, Kim C, Rowton M, Nadadur RD, Wang Z, Stocker M, Hoffmann AD, Hanson E, Kweon J, Sinha T, et al. Cell Rep. 2023 Jun 27; 42(6):112665. Epub 2023 Jun 17.